These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 19692558

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Susceptibility Testing of Common and Uncommon Aspergillus Species against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method.
    Mello E, Posteraro B, Vella A, De Carolis E, Torelli R, D'Inzeo T, Verweij PE, Sanguinetti M.
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28416538
    [Abstract] [Full Text] [Related]

  • 25. A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility.
    Mortensen KL, Johansen HK, Fuursted K, Knudsen JD, Gahrn-Hansen B, Jensen RH, Howard SJ, Arendrup MC.
    Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1355-63. PubMed ID: 21541671
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network.
    Balajee SA, Kano R, Baddley JW, Moser SA, Marr KA, Alexander BD, Andes D, Kontoyiannis DP, Perrone G, Peterson S, Brandt ME, Pappas PG, Chiller T.
    J Clin Microbiol; 2009 Oct; 47(10):3138-41. PubMed ID: 19675215
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
    Shi JY, Xu YC, Shi Y, Lü HX, Liu Y, Zhao WS, Chen DM, Xi LY, Zhou X, Wang H, Guo LN.
    Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
    [Abstract] [Full Text] [Related]

  • 32. Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole.
    Silvanose CD, Bailey TA, Di Somma A.
    Vet Rec; 2006 Aug 26; 159(9):282-4. PubMed ID: 16946311
    [Abstract] [Full Text] [Related]

  • 33. Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method.
    Espinel-Ingroff A, Chowdhary A, Gonzalez GM, Lass-Flörl C, Martin-Mazuelos E, Meis J, Peláez T, Pfaller MA, Turnidge J.
    Antimicrob Agents Chemother; 2013 Aug 26; 57(8):3823-8. PubMed ID: 23716059
    [Abstract] [Full Text] [Related]

  • 34. Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.
    Araujo R, Pina-Vaz C, Rodrigues AG.
    Int J Antimicrob Agents; 2007 Jan 26; 29(1):108-11. PubMed ID: 17189101
    [Abstract] [Full Text] [Related]

  • 35. Comparison of Etest with modified broth microdilution method for testing susceptibility of Aspergillus spp. to voriconazole.
    Serrano MC, Morilla D, Valverde A, Chávez M, Espinel-Ingroff A, Claro R, Ramírez M, Mazuelos EM.
    J Clin Microbiol; 2003 Nov 26; 41(11):5270-2. PubMed ID: 14605181
    [Abstract] [Full Text] [Related]

  • 36. In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method.
    Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ.
    J Clin Microbiol; 2009 Oct 26; 47(10):3323-5. PubMed ID: 19710267
    [Abstract] [Full Text] [Related]

  • 37. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.
    Badali H, Fakhim H, Zarei F, Nabili M, Vaezi A, Poorzad N, Dolatabadi S, Mirhendi H.
    Mycopathologia; 2016 Apr 26; 181(3-4):235-40. PubMed ID: 26615417
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Wild-type minimum effective concentration distributions and epidemiologic cutoff values for caspofungin and Aspergillus spp. as determined by Clinical and Laboratory Standards Institute broth microdilution methods.
    Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ.
    Diagn Microbiol Infect Dis; 2010 May 26; 67(1):56-60. PubMed ID: 20207095
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.